Picture of Advanced Oncotherapy logo

AVO Advanced Oncotherapy News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

REG - AIM - AIM Notice - 31/03/2022

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220331:nRSe6467Ga&default-theme=true

RNS Number : 6467G  AIM  31 March 2022

NOTICE

 

31/03/2022 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 ADVANCED ONCOTHERAPY PLC
 8,000,000  ORDINARY SHARES OF 25P EACH, FULLY PAID  (BD6SX10)(GB00BD6SX109)

 

 ECO (ATLANTIC) OIL & GAS LTD
 22,296,300  COMMON SHARES OF NO PAR VALUE FULLY PAID (DI)  (BYVQ3W7)(CA27887W1005)

 

 GREATLAND GOLD PLC
 6,000,000  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (B15XDH8)(GB00B15XDH89)

 

 GRESHAM HOUSE PLC
 200,000  ORDINARY SHARES OF 25P EACH, FULLY PAID  (0388728)(GB0003887287)

 

 LANSDOWNE OIL & GAS PLC
 60,000,000  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (B1250X2)(GB00B1250X28)

 

 MORTGAGE ADVICE BUREAU (HOLDINGS) PLC
 3,809,524  ORDINARY SHARES OF 0.1P EACH FULLY PAID  (BQSBH50)(GB00BQSBH502)

 

 PARSLEY BOX GROUP PLC
 27,957,799  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BNK9TZ5)(GB00BNK9TZ56)

 

 SDI GROUP PLC
 117,716  ORDINARY SHARES OF 1P EACH, FULLY PAID  (B3FBWW4)(GB00B3FBWW43)

 

 TIME OUT GROUP PLC                                       BLOCK ADMISSION
 2,000,000   ORDINARY SHARES OF GBP0.001 EACH FULLY PAID  (BYYV062)(GB00BYYV0629)

 

 VAST RESOURCES PLC
 14,772,333  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (BMD6804)(GB00BMD68046)

 

 WINDWARD LTD
 153,081  ORDINARY SHARES OF NIS0.002 EACH, FULLY PAID (DI)  (BNTVZP4)(IL0011809428)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBSGDXSXXDGDG

Recent news on Advanced Oncotherapy

See all news